<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01267019</url>
  </required_header>
  <id_info>
    <org_study_id>MHBB-004-10S</org_study_id>
    <nct_id>NCT01267019</nct_id>
  </id_info>
  <brief_title>Social Cognition Intervention</brief_title>
  <acronym>ASCI</acronym>
  <official_title>Augmenting Social Cognitive Intervention for Veterans With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Veterans with schizophrenia and schizoaffective disorder experience high levels of disability
      and poor community outcome, and these poor functional outcomes constitute a major public
      health concern. The treatment of schizophrenia spectrum disorders has shifted fundamentally
      from a focus on symptom reduction to a focus on recovery and improving aspects of
      functioning. Needed improvements in community outcome for patients with these disorders will
      not occur simply through better control of clinical symptoms. Instead, it is necessary to
      find new treatments that address the key determinants of poor functional outcome, including
      social cognition. Both basic (non-social) cognition and social cognition are considered key
      determinants of functional outcome for schizophrenia and schizoaffective disorder. Basic
      cognition includes the domains of: learning and memory, vigilance / attention, speed of
      processing, reasoning and problem solving, and working memory. Social cognition generally
      refers to mental operations that underlie social interactions, including perceiving,
      interpreting, managing, and generating responses to socially relevant stimuli, including the
      intentions and behaviors of others. As part of the investigators' previous Merit grant, they
      have developed a training program for social cognition and are in the process of validating
      it. Initial results suggest that the program improves performance on measures of social
      cognition and functional capacity.

      In this study, the investigators will evaluate whether adding an in vivo component (training
      activities that occur in the community) to the current social cognition intervention
      facilitates generalization of training effects to community outcome and subjective
      satisfaction. Outcome measures of social cognition and functional capacity will be examined
      during the 12 week training program, and durability of benefits will be assessed at a 3-month
      follow up. Generalization to community functioning and subjective satisfaction will be
      assessed at the end of training and at the 3-month follow up. The investigators will enroll
      105 patients across the 5 years of the study with random assignment to training group (social
      cognition intervention with in vivo exercises, social cognition intervention without in vivo
      exercises and control). Subjects will receive assessments at baseline, 6 weeks (mid-point),
      completion of training (12 weeks), and the 3-month follow up.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)</measure>
    <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
    <description>A standardized measure of emotion processing. It is scored as a standard score with a population mean of 100 and standard deviation of 15. It can range from 0 to 200. Higher is better.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Awareness of Social Inference Test (TASIT)</measure>
    <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
    <description>A measure of mentalizing (i.e., making inferences about other people). It is scored for accuracy in which higher is better. It ranges from 0 - 64.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profile of Nonverbal Sensitivity (PONS)</measure>
    <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
    <description>A measure of social perception. It is scored as number correct and higher is better. It ranges from 0 - 110.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Psychosis</condition>
  <arm_group>
    <arm_group_label>Arm 1: vivo augmentation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>social cognitive training with in vivo augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: social cognitive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>social cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3: non-social skills</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>non-social skills training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>social cognitive training with in vivo augmentation</intervention_name>
    <description>24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
    <arm_group_label>Arm 1: vivo augmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>social cognitive training</intervention_name>
    <description>30 sessions of social cognitive training without in vivo exercises</description>
    <arm_group_label>Arm 2: social cognitive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>non-social skills training</intervention_name>
    <description>30 sessions of skills training that has no specific social content</description>
    <arm_group_label>Arm 3: non-social skills</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients must be diagnosed with Schizophrenia, Schizoaffective Disorder, or Psychosis
        not otherwise specified (NOS) according to Diagnosis and Statistical Manual (DSM-IV)
        criteria. In addition, the subjects will meet the following criteria:

          -  Between 18 and 60 years of age

          -  Estimated premorbid intelligence quota &gt; 70 (based on reading ability)

          -  Understand spoken English sufficiently to comprehend testing procedures

          -  Clinically stable (e.g., no inpatient hospitalization in the 8 weeks prior to
             enrollment, no significant changes in medication in the 4 weeks prior to enrollment,
             and none anticipated for the 3 months of participation)

          -  In sufficient health to be able to walk outdoors unaided for at least 15 minutes.

        Exclusion Criteria:

          -  No clinically significant neurological disease as determined by medical history

          -  No history of serious head injury (e.g., loss of consciousness longer than 1 hour)

          -  No physical, cognitive, or language impairment of such severity as to adversely affect
             the validity of data

          -  No evidence of drug or alcohol dependence in the past six months, and not intoxicated
             at time of testing based on urine toxicology screen and saliva alcohol test strip.
             Subjects who test positive will not be disqualified but instead will be asked to
             return for testing on a different day. However, subjects who test positive on 3
             consecutive occasions will be disqualified from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael F Green, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2010</study_first_submitted>
  <study_first_submitted_qc>December 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2010</study_first_posted>
  <results_first_submitted>November 15, 2016</results_first_submitted>
  <results_first_submitted_qc>January 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 15, 2017</results_first_posted>
  <last_update_submitted>January 24, 2017</last_update_submitted>
  <last_update_submitted_qc>January 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>social cognition</keyword>
  <keyword>training intervention</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: Vivo Augmentation</title>
          <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Social Cognitive</title>
          <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
        </group>
        <group group_id="P3">
          <title>Arm 3: Non-social Skills</title>
          <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="47"/>
                <participants group_id="P3" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: Vivo Augmentation</title>
          <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Social Cognitive</title>
          <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
        </group>
        <group group_id="B3">
          <title>Arm 3: Non-social Skills</title>
          <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="47"/>
            <count group_id="B4" value="135"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.3" spread="11.3"/>
                    <measurement group_id="B2" value="48.8" spread="9.1"/>
                    <measurement group_id="B3" value="46.7" spread="10.2"/>
                    <measurement group_id="B4" value="47.3" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)</title>
        <description>A standardized measure of emotion processing. It is scored as a standard score with a population mean of 100 and standard deviation of 15. It can range from 0 to 200. Higher is better.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
        <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Vivo Augmentation</title>
            <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Social Cognitive</title>
            <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Non-social Skills</title>
            <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
          </group>
        </group_list>
        <measure>
          <title>Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)</title>
          <description>A standardized measure of emotion processing. It is scored as a standard score with a population mean of 100 and standard deviation of 15. It can range from 0 to 200. Higher is better.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.30" spread="1.12"/>
                    <measurement group_id="O2" value="87.30" spread="1.12"/>
                    <measurement group_id="O3" value="88.46" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.23" spread="1.16"/>
                    <measurement group_id="O2" value="89.23" spread="1.16"/>
                    <measurement group_id="O3" value="87.61" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.84" spread="1.76"/>
                    <measurement group_id="O2" value="89.78" spread="1.36"/>
                    <measurement group_id="O3" value="87.68" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.78" spread="1.87"/>
                    <measurement group_id="O2" value="90.42" spread="1.46"/>
                    <measurement group_id="O3" value="86.51" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>This is a statistical analysis to determine the training effect of social cognitive skills training (in vivo and social cog versus control).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; .05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Awareness of Social Inference Test (TASIT)</title>
        <description>A measure of mentalizing (i.e., making inferences about other people). It is scored for accuracy in which higher is better. It ranges from 0 - 64.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
        <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Vivo Augmentation</title>
            <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Social Cognitive</title>
            <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Non-social Skills</title>
            <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
          </group>
        </group_list>
        <measure>
          <title>The Awareness of Social Inference Test (TASIT)</title>
          <description>A measure of mentalizing (i.e., making inferences about other people). It is scored for accuracy in which higher is better. It ranges from 0 - 64.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.67" spread=".82"/>
                    <measurement group_id="O2" value="44.67" spread=".82"/>
                    <measurement group_id="O3" value="46.79" spread=".93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.45" spread=".77"/>
                    <measurement group_id="O2" value="45.45" spread=".77"/>
                    <measurement group_id="O3" value="46.22" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.00" spread="1.24"/>
                    <measurement group_id="O2" value="46.91" spread="1.05"/>
                    <measurement group_id="O3" value="46.81" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.83" spread="1.4"/>
                    <measurement group_id="O2" value="46.91" spread="1.05"/>
                    <measurement group_id="O3" value="46.73" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Profile of Nonverbal Sensitivity (PONS)</title>
        <description>A measure of social perception. It is scored as number correct and higher is better. It ranges from 0 - 110.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
        <time_frame>baseline, 6 weeks, 12 weeks, and 3 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Vivo Augmentation</title>
            <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Social Cognitive</title>
            <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Non-social Skills</title>
            <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
          </group>
        </group_list>
        <measure>
          <title>Profile of Nonverbal Sensitivity (PONS)</title>
          <description>A measure of social perception. It is scored as number correct and higher is better. It ranges from 0 - 110.
Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.76" spread=".91"/>
                    <measurement group_id="O2" value="75.76" spread=".91"/>
                    <measurement group_id="O3" value="77.41" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.90" spread=".79"/>
                    <measurement group_id="O2" value="78.90" spread=".79"/>
                    <measurement group_id="O3" value="79.24" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.83" spread="1.52"/>
                    <measurement group_id="O2" value="78.60" spread="1.04"/>
                    <measurement group_id="O3" value="79.89" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.72" spread="1.94"/>
                    <measurement group_id="O2" value="79.28" spread="1.28"/>
                    <measurement group_id="O3" value="80.56" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: Vivo Augmentation</title>
          <description>social cognitive training with in vivo augmentation
social cognitive training with in vivo augmentation: 24 sessions of social cognitive training plus 6 sessions of in vivo exercises</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Social Cognitive</title>
          <description>social cognitive training
social cognitive training: 30 sessions of social cognitive training without in vivo exercises</description>
        </group>
        <group group_id="E3">
          <title>Arm 3: Non-social Skills</title>
          <description>non-social skills training
non-social skills training: 30 sessions of skills training that has no specific social content</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>cardiac arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>diabetic incident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>acute exacerbation of symptoms</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="47"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael F. Green, PhD</name_or_title>
      <organization>VA Greater Los Angeles, VISN 22 MIRECC</organization>
      <phone>(310) 268-3376</phone>
      <email>mgreen@ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

